111 related articles for article (PubMed ID: 26973018)
1. Cyclic RGD peptides target human trabecular meshwork cells while ameliorating connective tissue growth factor-induced fibrosis.
Hennig R; Kuespert S; Haunberger A; Goepferich A; Fuchshofer R
J Drug Target; 2016 Dec; 24(10):952-959. PubMed ID: 26973018
[TBL] [Abstract][Full Text] [Related]
2. Activated αvβ3 integrin regulates αvβ5 integrin-mediated phagocytosis in trabecular meshwork cells.
Gagen D; Filla MS; Clark R; Liton P; Peters DM
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):5000-11. PubMed ID: 23821196
[TBL] [Abstract][Full Text] [Related]
3. Connective tissue growth factor induces extracellular matrix deposition in human trabecular meshwork cells.
Junglas B; Yu AH; Welge-Lüssen U; Tamm ER; Fuchshofer R
Exp Eye Res; 2009 Jun; 88(6):1065-75. PubMed ID: 19450452
[TBL] [Abstract][Full Text] [Related]
4. Cyclic RGD peptide-conjugated polyplex micelles as a targetable gene delivery system directed to cells possessing alphavbeta3 and alphavbeta5 integrins.
Oba M; Fukushima S; Kanayama N; Aoyagi K; Nishiyama N; Koyama H; Kataoka K
Bioconjug Chem; 2007; 18(5):1415-23. PubMed ID: 17595054
[TBL] [Abstract][Full Text] [Related]
5. The prostaglandin f2α analog fluprostenol attenuates the fibrotic effects of connective tissue growth factor on human trabecular meshwork cells.
Fuchshofer R; Kuespert S; Junglas B; Tamm ER
J Ocul Pharmacol Ther; 2014; 30(2-3):237-45. PubMed ID: 24576038
[TBL] [Abstract][Full Text] [Related]
6. Connective tissue growth factor causes glaucoma by modifying the actin cytoskeleton of the trabecular meshwork.
Junglas B; Kuespert S; Seleem AA; Struller T; Ullmann S; Bösl M; Bosserhoff A; Köstler J; Wagner R; Tamm ER; Fuchshofer R
Am J Pathol; 2012 Jun; 180(6):2386-403. PubMed ID: 22542845
[TBL] [Abstract][Full Text] [Related]
7. Anti-connective tissue growth factor antibody treatment reduces extracellular matrix production in trabecular meshwork and lamina cribrosa cells.
Wallace DM; Clark AF; Lipson KE; Andrews D; Crean JK; O'Brien CJ
Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):7836-48. PubMed ID: 24204045
[TBL] [Abstract][Full Text] [Related]
8. The regulation of connective tissue growth factor expression influences the viability of human trabecular meshwork cells.
Kuespert S; Junglas B; Braunger BM; Tamm ER; Fuchshofer R
J Cell Mol Med; 2015 May; 19(5):1010-20. PubMed ID: 25704370
[TBL] [Abstract][Full Text] [Related]
9. Kidney podocytes as specific targets for cyclo(RGDfC)-modified nanoparticles.
Pollinger K; Hennig R; Breunig M; Tessmar J; Ohlmann A; Tamm ER; Witzgall R; Goepferich A
Small; 2012 Nov; 8(21):3368-75. PubMed ID: 22888052
[TBL] [Abstract][Full Text] [Related]
10. A selective cyclic integrin antagonist blocks the integrin receptors alphavbeta3 and alphavbeta5 and inhibits retinal pigment epithelium cell attachment, migration and invasion.
Hoffmann S; He S; Jin M; Ehren M; Wiedemann P; Ryan SJ; Hinton DR
BMC Ophthalmol; 2005 Jun; 5():16. PubMed ID: 15987521
[TBL] [Abstract][Full Text] [Related]
11. Regulation of cross-linked actin network (CLAN) formation in human trabecular meshwork (HTM) cells by convergence of distinct beta1 and beta3 integrin pathways.
Filla MS; Schwinn MK; Sheibani N; Kaufman PL; Peters DM
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5723-31. PubMed ID: 19643963
[TBL] [Abstract][Full Text] [Related]
12. MiR-18a-5p Targets Connective Tissue Growth Factor Expression and Inhibits Transforming Growth Factor β2-Induced Trabecular Meshwork Cell Contractility.
Knox J; Bou-Gharios G; Hamill KJ; Willoughby CE
Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011411
[TBL] [Abstract][Full Text] [Related]
13. Activation of αvβ3 Integrin Alters Fibronectin Fibril Formation in Human Trabecular Meshwork Cells in a ROCK-Independent Manner.
Filla MS; Faralli JA; Desikan H; Peotter JL; Wannow AC; Peters DM
Invest Ophthalmol Vis Sci; 2019 Sep; 60(12):3897-3913. PubMed ID: 31529121
[TBL] [Abstract][Full Text] [Related]
14. Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma.
Wordinger RJ; Fleenor DL; Hellberg PE; Pang IH; Tovar TO; Zode GS; Fuller JA; Clark AF
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1191-200. PubMed ID: 17325163
[TBL] [Abstract][Full Text] [Related]
15. Overexpression and Activation of αvβ3 Integrin Differentially Affects TGFβ2 Signaling in Human Trabecular Meshwork Cells.
Filla MS; Meyer KK; Faralli JA; Peters DM
Cells; 2021 Jul; 10(8):. PubMed ID: 34440692
[TBL] [Abstract][Full Text] [Related]
16. RGD-modified polymeric micelles as potential carriers for targeted delivery to integrin-overexpressing tumor vasculature and tumor cells.
Wang Y; Wang X; Zhang Y; Yang S; Wang J; Zhang X; Zhang Q
J Drug Target; 2009 Jul; 17(6):459-67. PubMed ID: 19527117
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor binding protein-5 expression by human trabecular meshwork.
Wirtz MK; Xu H; Rust K; Alexander JP; Acott TS
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):45-53. PubMed ID: 9430544
[TBL] [Abstract][Full Text] [Related]
18. α5β1 Integrin Promotes Anchoring and Integration of Transplanted Stem Cells to the Trabecular Meshwork in the Eye for Regeneration.
Xiong S; Xu Y; Wang Y; Kumar A; Peters DM; Du Y
Stem Cells Dev; 2020 Mar; 29(5):290-300. PubMed ID: 31854234
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone-associated cross-linked actin network formation in human trabecular meshwork cells involves β3 integrin signaling.
Filla MS; Schwinn MK; Nosie AK; Clark RW; Peters DM
Invest Ophthalmol Vis Sci; 2011 May; 52(6):2952-9. PubMed ID: 21273548
[TBL] [Abstract][Full Text] [Related]
20. High-Affinity RGD-Knottin Peptide as a New Tool for Rapid Evaluation of the Binding Strength of Unlabeled RGD-Peptides to α
Bernhagen D; De Laporte L; Timmerman P
Anal Chem; 2017 Jun; 89(11):5991-5997. PubMed ID: 28492301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
